Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury | VBIO Stock NewsStockTitan·14 hours agoVBIO-27.10%
Valion Bio issues 1,287 Series A preferred shares in unregistered sale tied to $750,000 milestone paymentPUBT·Aug 6 at 03:51 PMVBIO-27.10%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jul 24 at 04:05 PMITOC+6.21%SXTC-5.98%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 20 at 07:05 AMBRNS+1.25%VBIO-27.10%
World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market | VBIO Stock NewsStockTitan·Jul 20 at 04:28 AMVBIO-27.10%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 14 at 12:05 PMGALT+0.32%CARL-0.07%
07:45 ETValion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansionprnewswire·Jul 14 at 06:46 AMVBIO-27.10%
